171 results on '"Tjwa, Eric"'
Search Results
2. Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma
3. Liver steatosis is prevalent in lean people living with HIV and associated with exposure to antiretroviral treatment – a cross-sectional study
4. Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative
5. Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
6. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
7. Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment—A Cross-sectional Study.
8. Transarterial Chemoembolization With Drug-Eluting Beads Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Outcomes From a Multicenter, Randomized, Phase 2 Trial (the TRENDY Trial)
9. PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
10. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
11. Functional Testing in the Diagnosis of Chronic Mesenteric Ischemia
12. Elastografie van de lever met de Fibroscan®
13. Aetiology and outcome of adult and paediatric acute liver failure in Europe
14. Noninvasive Staging of Hepatic Steatosis Using Calibrated 2D US with Liver Biopsy as the Reference Standard
15. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis
16. TACE-DEB vs. SBRT for hepatocellular carcinoma
17. Imaging the Lymphatic System in Fontan Patients: Toward Robust Quantification of Functional and Structural Abnormalities in Single Ventricle Physiology
18. Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe.
19. Hypoxia-inducible factor 1-α in chronic gastrointestinal ischemia
20. Covered Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Therapy + β-Blocker for Prevention of Variceal Rebleeding
21. Functional Testing in the Diagnosis of Chronic Mesenteric Ischemia
22. Refractory Hypoxemia in a 23-Year-Old Patient With Budd-Chiari Syndrome
23. A limited role of cytokine storm and fibrogenesis in COVID-19 related liver injury
24. Editorial: Beta blockers and cirrhosis—more than just portal hypertension?
25. Venous Stent Placement for Refractory Ascites due to Hepatic Venous Outflow Obstruction in Polycystic Liver Disease
26. Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009–2016
27. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
28. Malignancy Presenting as Multiple Lesions in a Cirrhotic Liver: Not Always Hepatocellular Carcinoma
29. Additional file 5: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes
30. Additional file 1: of Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes
31. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study
32. Nationwide treatment and outcomes of perihilar cholangiocarcinoma.
33. Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
34. Management of portal hypertension and ascites in polycystic liver disease
35. A Novel Automatic Digital Algorithm that Accurately Quantifies Steatosis in NAFLD on Histopathological Whole‐Slide Images
36. Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes
37. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients
38. Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease
39. PREVALENCE AND FACTORS ASSOCIATED WITH NAFLD IN PEOPLE WITH HIV.
40. Management of ruptured hepatocellular carcinoma in a European tertiary care center
41. Endoscopic Therapy Plus Beta Blocker Is Still the First Choice for Prevention of Variceal Rebleeding? REPLY
42. Notice of Removal: Staging hepatic steatosis in nonalcoholic fatty liver disease by quantitative conventional ultrasound imaging, validated with histopathology
43. Computer-assisted instruction before colonoscopy is as effective as nurse counselling, a clinical pilot trial
44. Diagnostic Accuracy of the Combination of Clinical Symptoms and CT or MR Angiography in Patients With Chronic Gastrointestinal Ischemia
45. Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study
46. Malignancy Presenting as Multiple Lesions in a Cirrhotic Liver: Not Always Hepatocellular Carcinoma
47. Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
48. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.
49. Short article
50. Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.